Infectious events during all 3 ASNase-containing courses
| Event type . | Pegaspargase (%) . | Native ASNase (%) . |
|---|---|---|
| Bacteremia | 17 (29) | 17 (29) |
| Life-threatening sepsis | 2 (3) | 1 (2) |
| Pneumonia | 2 (3) | 2 (3) |
| Varicella zoster virus | 5 (8) | 1 (2) |
| Urinary tract infection | 0 (0) | 3 (5) |
| Cellulitis/skin infection | 2 (3) | 1 (2) |
| Clostridium difficile | 3 (5) | 2 (3) |
| Pneumocystis | 0 (0) | 1 (2) |
| Fungal stomatitis | 0 (0) | 1 (2) |
| Herpes simplex | 0 (0) | 1 (2) |
| Event type . | Pegaspargase (%) . | Native ASNase (%) . |
|---|---|---|
| Bacteremia | 17 (29) | 17 (29) |
| Life-threatening sepsis | 2 (3) | 1 (2) |
| Pneumonia | 2 (3) | 2 (3) |
| Varicella zoster virus | 5 (8) | 1 (2) |
| Urinary tract infection | 0 (0) | 3 (5) |
| Cellulitis/skin infection | 2 (3) | 1 (2) |
| Clostridium difficile | 3 (5) | 2 (3) |
| Pneumocystis | 0 (0) | 1 (2) |
| Fungal stomatitis | 0 (0) | 1 (2) |
| Herpes simplex | 0 (0) | 1 (2) |